Cargando…

Allogeneic Mesenchymal Precursor Cells (MPC) in Diabetic Nephropathy: A Randomized, Placebo-controlled, Dose Escalation Study

BACKGROUND: Diabetic nephropathy is the most common cause of end stage renal failure. We assessed the safety, tolerability, and explored therapeutic effects of adult allogeneic bone-marrow derived mesenchymal precursor cells (MPC) in patients with moderate to severe diabetic nephropathy. METHODS: Mu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Packham, David K., Fraser, Ian R., Kerr, Peter G., Segal, Karen R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5078602/ https://www.ncbi.nlm.nih.gov/pubmed/27743903 http://dx.doi.org/10.1016/j.ebiom.2016.09.011

Ejemplares similares

Allogeneic Mesenchymal Precursor Cells in Type 2 Diabetes: A Randomized, Placebo-Controlled, Dose-Escalation Safety and Tolerability Pilot Study
por: Skyler, Jay S., et al.
Publicado: (2015)

Curcumin alleviates diabetic nephropathy via inhibiting podocyte mesenchymal transdifferentiation and inducing autophagy in rats and MPC5 cells
por: Tu, Qiudi, et al.
Publicado: (2019)

MPC construction techniques
Publicado: (1971)

MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancer
por: Li, Xiaoli, et al.
Publicado: (2016)

Dasiglucagon Effects on QTc in Healthy Volunteers: A Randomized, Placebo-Controlled, Dose-Escalation, Double-Blind Study
por: Tehranchi, Ramin, et al.
Publicado: (2022)

MPC850 integrated communications microprocessor : user's manual.
Publicado: (1998)

Metaplectic representation, MPC structures and geometric quantization
por: Rawnsley, JH, et al.
Publicado: (1989)

C-Terminal Binding Protein 1 Modulates Cellular Redox via Feedback Regulation of MPC1 and MPC2 in Melanoma Cells
por: Deng, Yu, et al.
Publicado: (2018)

Long‐term experience of MPC across multiple TrueBeam linacs: MPC concordance with conventional QC and sensitivity to real‐world faults
por: Pearson, Michael, et al.
Publicado: (2020)

Treatment of Common Cold Patients with the Shi-Cha Capsule: A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Dose-Escalation Trial
por: Chang, Jing, et al.
Publicado: (2012)

Randomized, double-blind, placebo-controlled phase I dose escalation study of Dan Qi Tong Mai tablet in healthy volunteers
por: Gou, Zhong-ping, et al.
Publicado: (2019)

A Randomized, Double‐Blind, Placebo‐Controlled, Multiple Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of ELX‐02 in Healthy Subjects
por: Leubitz, Andi, et al.
Publicado: (2021)

Decomposition–Coordination of Double-Layer MPC for Constrained Systems
por: Wang, Hongrui, et al.
Publicado: (2022)

A Double-Blind, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of JDTic
por: Buda, Jeffrey J, et al.
Publicado: (2015)

Phase 1 Randomized, Placebo-Controlled, Dose-Escalating Study to Evaluate OVX836, a Nucleoprotein-Based Influenza Vaccine: Intramuscular Results( )
por: Withanage, Kanchanamala, et al.
Publicado: (2021)

Feasibility of Dose Escalation in Patients With Intracranial Pediatric Ependymoma
por: Tensaouti, Fatima, et al.
Publicado: (2019)

Radiation treatment planning with embedded dose escalation
por: Hrinivich, William T., et al.
Publicado: (2019)

Randomized dose-escalation trial of elamipretide in adults with primary mitochondrial myopathy
por: Karaa, Amel, et al.
Publicado: (2018)

A Double-Blind, Placebo-Controlled Trial Demonstrating the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336
por: Carroll, F. Ivy, et al.
Publicado: (2018)

Nonlinear observer output-feedback MPC treatment scheduling for HIV
por: Zurakowski, Ryan
Publicado: (2011)

Structural and functional divergence of the Mpc1 genes in wheat and barley
por: Strygina, Ksenia V., et al.
Publicado: (2019)

MPC-15 FEASIBILITY OF GLIOMA SPECIFIC ONCOPANEL IN THE DIAGNOSIS OF GLIOMA
por: Yoshimoto, Koji, et al.
Publicado: (2019)

MPC-18 CATEGORIZATION OF LOWER GRADE GLIOMA USING ONCOPANEL
por: Uchida, Hiroyuki, et al.
Publicado: (2019)

MPC-05 TUMOR RELATED EPILEPSY AND IDH MUTATIONS IN GLIOMAS
por: Wakabayashi, Hikaru, et al.
Publicado: (2019)

Neural Flocking: MPC-Based Supervised Learning of Flocking Controllers
por: Mehmood, Usama, et al.
Publicado: (2020)

Distributed MPC of vehicle platoons with guaranteed consensus and string stability
por: Feng, Yangyang, et al.
Publicado: (2023)

Phase 1, placebo-controlled, dose escalation trial of chicory root extract in patients with osteoarthritis of the hip or knee
por: Olsen, Nancy J, et al.
Publicado: (2010)

Multiple doses of SHR-1222, a sclerostin monoclonal antibody, in postmenopausal women with osteoporosis: A randomized, double-blind, placebo-controlled, dose-escalation phase 1 trial
por: Dai, Zhijie, et al.
Publicado: (2023)

Safety of sildenafil in premature infants with severe bronchopulmonary dysplasia (SILDI-SAFE): a multicenter, randomized, placebo-controlled, sequential dose-escalating, double-masked, safety study
por: Schneider, Simone, et al.
Publicado: (2020)

XG-102 administered to healthy male volunteers as a single intravenous infusion: a randomized, double-blind, placebo-controlled, dose-escalating study
por: Deloche, Catherine, et al.
Publicado: (2014)

Safety and Pharmacokinetics of the Oral TYK2 Inhibitor PF‐06826647: A Phase I, Randomized, Double‐Blind, Placebo‐Controlled, Dose‐Escalation Study
por: Singh, Ravi Shankar P., et al.
Publicado: (2020)

P1535: SAFETY AND TOLERABILITY OF SINGLE ESCALATING DOSES OF INTRAVENOUS NIPOCALIMAB IN HEALTHY JAPANESE ADULTS: A RANDOMIZED, PHASE 1 PLACEBO-CONTROLLED STUDY
por: Leu, J., et al.
Publicado: (2022)

Safety and Tolerability, Dose-Escalating, Double-Blind Trial of Oral Mannitol in Parkinson's Disease
por: Linetsky, Eduard, et al.
Publicado: (2022)

Treatment of acute respiratory distress syndrome with allogeneic adipose-derived mesenchymal stem cells: a randomized, placebo-controlled pilot study
por: Zheng, Guoping, et al.
Publicado: (2014)

Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial
por: Tompkins, Bryon A, et al.
Publicado: (2017)

An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults
por: Woods, Christopher W., et al.
Publicado: (2019)

Dose escalation of a curcuminoid formulation
por: Lao, Christopher D, et al.
Publicado: (2006)

Pharmacokinetics of escalating single‐dose administration of cannabidiol to cats
por: Rozental, Aaron J., et al.
Publicado: (2022)

Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I, Healthy Subjects Study of Intravenous OPN-305, a Humanized Anti-TLR2 Antibody
por: Reilly, M, et al.
Publicado: (2013)

Incoherent dose-escalation in phase I trials using the escalation with overdose control approach
por: Wheeler, Graham M.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0il1i7rmmlc3qcuk37h5nf78le